VAERS Reports U0273657

VAERS 2466601

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U0273657

mild

Staat: OH
Alter: 53,0
Geschlecht: F
Eingang: 01.10.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Inflammation Injection site bruising Injection site erythema Injection site pain Injection site pruritus Injection site swelling Insomnia Peripheral swelling Skin warm

Symptomtext

Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT CALLED TODAY TO SHARE POTENTIAL VACCINE ADVERSE EVENTS WITH COMPLAIN ABOUT REDNESS, INFLAMMATION, HOT TO TOUCH, AND SWELLING OF THE UPPER HAND. PATIENT'S CONSULT WAS PROVIDED TO APPLY ICE, USE TYLENOL FOR PAIN/DISCOMFORT AND TO BE IN TOUCH WITH DOCTOR/PHARMACY FOR ANY WORSENING SIGNS/SYMPTOMS. PATIENT IS MADE AWARE OF REGULAR FOLLOW UP WITH HER DR'S OFFICE AND TO HERSELF TO SEE HOW THINGS ARE PORGRESSING

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -